TickerFacts.

Lunai Bioworks Inc. (LNAI): Capital Expenditures

Annual figures by period end, from SEC filings.

$1.2K
Year ended 2026-06-30
-65.4%
3-year compound annual growth
-52.1%
5-year compound annual growth
$716.7K2018-06-30: $30.0K2019-06-30: $716.7K2020-06-30: $184.5K2021-06-30: $48.9K2022-06-30: $5.2K2023-06-30: $29.8K2024-06-30: $70.4K2026-06-30: $1.2K$1.2K
2018-06-30 Capital Expenditures (USD) 2026-06-30
Period endedCapital ExpendituresChange YoYSource filing
2026-06-30$1.2Kn/a2026-10-13, From 2025-07-01
No annual figure between 2024-06-30 and 2026-06-30.
2024-06-30$70.4K+136.5%2025-09-29, From 2023-07-01
2023-06-30$29.8K+477.5%2025-02-19, From 2022-07-01
2022-06-30$5.2K-89.5%2023-10-02, From 2021-07-01
2021-06-30$48.9K-73.5%2023-02-27, From 2020-07-01
2020-06-30$184.5K-74.3%2021-09-24, From 2019-07-01
2019-06-30$716.7Kn/m2020-09-23, From 2018-07-01
2018-06-30$30.0Kn/a2019-09-30, From 2017-07-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Lunai Bioworks Inc. (LNAI)2026-06-30$1.2Kn/a
HCW Biologics Inc. (HCWB)2025-12-31$0-100.0%
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$434.0K-42.1%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$285.7K-41.4%
Altimmune, Inc. (ALT)2025-12-31$11.0Kn/a
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$500.0Kn/a
Lyell Immunopharma, Inc. (LYEL)2025-12-31$780.0K+68.1%
Actinium Pharmaceuticals, Inc. (ATNM)2025-12-31$104.0K+845.5%
iBio, Inc. (IBIO)2026-06-30$578.0Kn/m

Compare LNAI, HCWB, CNTB, INO side by side · Screen every company in Pharmaceutical Preparations ↗